Wang, K., Tomaras, G. D., Jegaskanda, S., Moody, M. A., Liao, H., Goodman, K. N., . . . Cohen, J. I. (2017). Monoclonal Antibodies, Derived from Humans Vaccinated with the RV144 HIV Vaccine Containing the HVEM Binding Domain of Herpes Simplex Virus (HSV) Glycoprotein D, Neutralize HSV Infection, Mediate Antibody-Dependent Cellular Cytotoxicity, and Protect Mice from Ocular Challenge with HSV-1. J Virol.
Style de citation ChicagoWang, Kening, et al. "Monoclonal Antibodies, Derived From Humans Vaccinated With the RV144 HIV Vaccine Containing the HVEM Binding Domain of Herpes Simplex Virus (HSV) Glycoprotein D, Neutralize HSV Infection, Mediate Antibody-Dependent Cellular Cytotoxicity, and Protect Mice From Ocular Challenge With HSV-1." J Virol 2017.
Style de citation MLAWang, Kening, et al. "Monoclonal Antibodies, Derived From Humans Vaccinated With the RV144 HIV Vaccine Containing the HVEM Binding Domain of Herpes Simplex Virus (HSV) Glycoprotein D, Neutralize HSV Infection, Mediate Antibody-Dependent Cellular Cytotoxicity, and Protect Mice From Ocular Challenge With HSV-1." J Virol 2017.